The legal skirmish began when Amarin filed a lawsuit five years ago accusing Hikma Pharmaceuticals of infringing three patents
In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy over so-called skinny labels for medicines, arguing that an appeals court finding threatens the availability of lower-cost generic drugs.
Skinny… [790 chars]
Source: STAT | Published: 2025-12-09T21:43:10Z
Credit: STAT
